𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Human T-cell lymphotropic virus type I (HTLV-I) antibodies in pre-diagnostic serum of patients with familial adult T-cell leukemia/lymphoma (ATL)

✍ Scribed by Abraham M. Y. Nomura; Eugene T. Yanagihara; William A. Blattner; Gloria Y. F. Ho; Melvin S. Inamasu; Richard K. Severson; Jeffrey M. Nakamura


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Volume
8
Category
Article
ISSN
0278-0232

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

In a study of 7498 American men of Japanese ancestry in Hawaii, 26 incident cases of leukemia or non‐Hodgkin's lymphoma were identified after a follow‐up period of 19 years. Two of the cases, who were brothers, were diagnosed with adult T‐cell leukemia/lymphoma (ATL). Both of these brothers had human T‐cell lymphotropic virus type I (HTLV‐I) antibodies in their stored serum which were obtained 4 and 18 years before diagnosis. None of the 24 patients with other hematologic malignancies or the 26 matched controls were HTLV‐I antibody positive. This finding lends further support for a role of HTLV‐I in the etiology of adult T‐cell leukemia/lymphoma.


πŸ“œ SIMILAR VOLUMES


Serum dehydroepiandrosterone and DHEA-su
✍ Uozumi, Kimiharu; Uematsu, Toshiaki; Otsuka, Maki; Nakano, Satoko; Takatsuka, Yo πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 445 KB πŸ‘ 2 views

The serum levels of dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S) were determined by radioimmunoassay in 38 patients with adult T-cell leukemia (ATL). Levels of serum DHEA and DHEA-S were also measured in 60 human T-lymphotropic virus type I (HTLV-I) carriers, and did not differ from those

Modelling the risk of adult T-cell leuke
✍ E. L. Murphy; B. Hanchard; J. P. Figueroa; W. N. Gibbs; W. S. Lofters; M. Campbe πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 French βš– 434 KB πŸ‘ 2 views

Adult T-cell leukernidlymphoma (ATL), a malignancy of mature CDCpositive lymphocytes, has been etiologically linked to the human retrovirus HTLV-I. Although a long latent period is suggested from migrant studies, little prospective information on the risk of developing ATL among persons with HTLV-I